An interventional study of transcranial electric stimulation in Traumatic Brain Injury, sponsored by Friedhelm Hummel. Completed at 2 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-12.
Sponsored by Friedhelm Hummel · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Brain Injuries, Traumatic with a site in Switzerland — 6 open to participants now, 8 under way, 2 of them phase 3. Brain Injuries, Traumatic · Switzerland.
Among the 31 studies in Brain Injuries, Traumatic with a site in Switzerland, this one is the 16th largest by enrollment of the 23 interventional ones that give a count, is the only one that started in 2021, is one of 18 with no phase, and was the 26th registered.
1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.
Browse Brain Injuries, Traumatic studies →6 of the 31 studies in Brain Injuries, Traumatic with a site in Switzerland are open now. Recruiting first, the newest first:
Luzerner Kantonsspital · Sites in Switzerland
Ages 18+
Dominik Straumann · Sites in Switzerland
Ages 18–60 · Healthy volunteers
Australian and New Zealand Intensive Care Research Centre · Sites in Switzerland, Australia, Belgium and 6 more countries
Ages 18–75
Luzerner Kantonsspital · Sites in Switzerland
Ages 18–80
Cereneo AG · Sites in Switzerland
Ages 18+
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2021.
This study's enrollment of 19 is below the median of 52 across 1,091 interventional studies indexed under Brain Injuries, Traumatic.
Median enrollment 25 across the 23 interventional studies, 63 across the 8 observational. Of the 21 that completed or were terminated, 2 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 31 have an industry lead sponsor. The 10 most frequent:
Friedhelm Hummel is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Friedhelm Hummel has 2 studies filed under Brain Injuries, Traumatic — fewer than ten, so there is no comparison to draw.
2 of the studies in Brain Injuries, Traumatic with a site in Switzerland that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04588311Phase 3Australian and New Zealand Intensive Care Research CentreErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients | 2026-12-31 |
| NCT06893029Dominik StraumannDizziness Due to Visual Stimuli in Patients With Concussion and Other Causes of Dizziness: Examination of Balance Behaviour | 2027-04-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 31 studies in Brain Injuries, Traumatic with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Acute and chronic cognitive impairment (TBI and MCI) is one of the most common problems in the growing and aging society of the 21st century. At an individual level, not all brain structures are affected with the same rate. There are subcortical structures less involved (e.g., the cerebellum), and other more involved (e.g., the hippocampus) in the cognitive decline with age or following a traumatism. To pave the way for personalized precision medicine in the field of cognitive preservation and recovery, there is a need for testing the impact of individually tailored innovative non-invasive neuro-technologies. In this project, we aim at testing the benefit of non-invasively stimulating subcortical structures to boost resilience in supporting motor and non-motor memory.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
TBI patients:
Exclusion Criteria:
Unable to consent
for NIBS or MRI (1):
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Sham stimulation : ramp-up \[5 s\] immediately followed by ramp-down \[5 s\] of high-frequency currents (see Vassiliadis et al., 2023, Nat Hum Behav for more details)
Other: transcranial electric stimulation
Patterned stimulation (intermittent theta-burst) generating temporal interference in the striatum; see Wessel et al., 2023, Nat Neurosci. for details
Other: transcranial electric stimulation
tTIS is an innovative non-invasive brain stimulation approach, in which two or more independent stimulation channels deliver high-frequency currents in the kHz range (oscillating at f1 and f1 + Δf). These high-frequency currents are assumed to be too high to effectively modulate neuronal activity. Still, by applying a small shift in frequency, they result in a modulated electric field with the envelope oscillating at the low-frequency Δf (target frequency) where the two currents overlap. The peak of the modulated envelope amplitude can be steered towards specific areas located deep in the brain, by tuning the positions of the electrodes and the current ratio across stimulation channels. Here, we applied tTIS via surface electrodes applying a low-intensity (2mA baseline to peak), sub-threshold protocol following the safety guidelines for low-intensity transcranial electric stimulation in humans.
Motor learning performance
The primary outcome of the study is the amount of motor learning in a sequential finger-tapping task evaluated during and following training
Time frame: From baseline to 24 hours after training
Brain connectivity
Diffusion-weighted and resting-state MRI is performed at baseline and allows to evaluate inter-individual anatomical factors associated to the primary outcome
Time frame: Baseline measure (before the intervention)
Demographic factors form
These factors including age, sex, handedness, education level and profession, time of diagnosis, physical activity, independency and quality of life, medication, cognitive status will are used to evaluate responsiveness to the intervention
Time frame: Baseline measure (before the intervention)
Plan to share: Undecided
Ran from Sep 2021 to primary completion in Feb 2024, 28 months.
Of 445 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's 28 months is below that.
Counting every sponsor, half of 467 studies reached it within 41 months; a quarter within 22 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Friedhelm Hummel